Clinical trial
Efficacy, Safety and Pharmacokinetic of ArtequinTM P. Falciparum Malaria
NCT00243737 · Albert Schweitzer Hospital, Other · Completed
Key facts
| NCT number | NCT00243737 |
|---|---|
| Title | Efficacy, Safety and Pharmacokinetic of ArtequinTM P. Falciparum Malaria |
| Official title | Open-label, Stratified Study on the Efficacy, Safety and Pharmacokinetic Characteristics of Two Paediatric Formulations of ArtequinTM in Children With Acute Uncomplicated P. Falciparum Malaria |
| Lead sponsor | Albert Schweitzer Hospital, Other |
| Collaborators | Mepha Ltd. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | Artesunate-Mefloquine |
| Enrollment | 70 |
| Start date | Oct 1, 2005 |
| Completion | Apr 1, 2006 |
| First posted | Oct 25, 2005 |
| Last update posted | Jan 24, 2013 |
| Countries | Gabon |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: